204 related articles for article (PubMed ID: 21045685)
1. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
Bussey KJ; Demeure MJ
Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinoma.
Soon PS; Sidhu SB
Cancer Treat Res; 2010; 153():187-210. PubMed ID: 19957226
[No Abstract] [Full Text] [Related]
3. Molecular markers and targeted therapies for adrenocortical carcinoma.
Xu Y; Qi Y; Zhu Y; Ning G; Huang Y
Clin Endocrinol (Oxf); 2014 Feb; 80(2):159-68. PubMed ID: 24304415
[TBL] [Abstract][Full Text] [Related]
4. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of adrenocortical carcinomas.
Soon PS; Sidhu SB
Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
[TBL] [Abstract][Full Text] [Related]
6. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.
Ganeshan D; Bhosale P; Kundra V
AJR Am J Roentgenol; 2012 Dec; 199(6):1283-93. PubMed ID: 23169720
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging therapies for adrenocortical carcinoma--review.
Przytulska J; Rogala N; Bednarek-Tupikowska G
Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in adrenocortical carcinoma in adults.
Bourdeau I; MacKenzie-Feder J; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
[TBL] [Abstract][Full Text] [Related]
9. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
10. PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH.
Miller BS; Else T;
Endocr Pract; 2017 Jun; 23(6):705-715. PubMed ID: 28614035
[TBL] [Abstract][Full Text] [Related]
11. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
Strosberg JR
Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinoma: review and update.
Erickson LA; Rivera M; Zhang J
Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinoma.
Baudin E;
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
16. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
17. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy: new strategies for the treatment of adrenocortical carcinoma.
Schott M; Reincke M; Ortmann D; Bornstein SR
Horm Metab Res; 2003 Jul; 35(7):451-3. PubMed ID: 12931278
[No Abstract] [Full Text] [Related]
20. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]